Old Web
English
Sign In
Acemap
>
authorDetail
>
Matthias Kretschmer
Matthias Kretschmer
Alnylam Pharmaceuticals
Oligonucleotide
Pharmacology
Medicine
Drug development
Active ingredient
3
Papers
30
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Abstract 67: Phase I Safety, Pharmacokinetic, and Pharmacodynamic Results for ALN-PCS, a Novel RNAi Therapeutic for the Treatment of Hypercholesterolemia
2012
Arteriosclerosis, Thrombosis, and Vascular Biology
Kevin Fitzgerald
Maria Frank-Kamenetsky
Timothy Mant
James M. Ritter
Joseph Chiesa
Malathy Munasamy
Renta Hutabarat
Valerie Clausen
David Watkins
Kimberly Smith
Jessica Sutherland
Jeff Cehelsky
Matthias Kretschmer
Lubomir Nechev
Verena Karsten
Sara Nochur
Lauri Binne
Akshay Vaishnaw
Amy Simon
Show All
Source
Cite
Save
Citations (8)
Quality Aspects of Oligonucleotide Drug Development: Specifications for Active Pharmaceutical Ingredients:
2012
Drug Information Journal
Daniel C. Capaldi
Kathy Ackley
Doug Brooks
Judy Carmody
Ken Draper
Rao Kambhampati
Matthias Kretschmer
Daren Levin
James V. McArdle
Bernhard Noll
Ramesh Raghavachari
Ipsita Roymoulik
B.P. (Bob) Sharma
René Thürmer
Fran Wincott
Show All
Source
Cite
Save
Citations (16)
An automated algorithm for sequence confirmation of chemically modified oligonucleotides by tandem mass spectrometry
2010
Analytical Biochemistry
Matthias Kretschmer
Gary Lavine
James McArdle
Satya Kuchimanchi
Veeravagu Murugaiah
Muthiah Manoharan
Show All
Source
Cite
Save
Citations (6)
1